ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Paris, Île-de-France, FRA:

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes (DF-IL2-REP)

Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory...

Enrolling
Type 1 Diabetes
Drug: Cyclosporin
Drug: ILT101

Phase 2

Assistance Publique - Hôpitaux de Paris

Paris, France

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Paris, France and 64 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Paris, France and 89 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Paris, France and 37 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Bondy, France and 78 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Paris, France and 652 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

Phase 2

ITBMed

Paris, France and 37 other locations

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous gluco...

Active, not recruiting
Diabetes Mellitus, Type 1
Device: Omnipod 5 System
Insulet

Paris, France and 18 other locations

Evolucare OphtAI is a medical device offering automated, artificial intelligence powered, screening capabilities for Diabetic Retinopathy, D...

Enrolling
Diabetic Macular Edema
Diabetic Retinopathy
Device: Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device
Evolucare Technologies

Paris, Île De France, France and 11 other locations

The purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with type 2 diabetes...

Active, not recruiting
Type2 Diabetes
Diabetes Mellitus
Drug: Placebo
Drug: Tirzepatide Dose 2

Phase 3

Lilly
Lilly

Paris, France and 51 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems